Episode 175: People-Powered MS Research with the CEO of iConquerMS Sara Loud

Episode 175: People-Powered MS Research with the CEO of iConquerMS Sara Loud

Publication date: Jan 04, 2021

Research creates the future for people affected by MS. And clinical research can’t happen without your participation. Joining me as my guest is Sara Loud, the CEO of iConquerMS, the people-powered-research network that puts you at the center of MS research. We’re also celebrating a whole list of MS advocacy wins that will translate into making life better for people living with MS in the United States. We’ll tell you about a study that clearly demonstrates why it’s essential to start disease-modifying therapy once someone receives an MS diagnosis. We’re sharing the results of a study about MS-related pain. And we’ll tell you about a new set of Amazon Alexa features that make being a long-distance care partner easier. We have a lot to talk about! Are you ready for RealTalk MS??! Celebrating MS advocacy wins :26 Effects of disease-modifying therapy on disability among people living with relapsing-remitting MS over 15 years 4:33 Study reveals new information about MS pain 6:01 Amazon Alexa has new features especially for care partners 9:11 My interview with Sara Loud 11:58 Share this episode 28:39 Donate to the National MS Society COVID-19 Response Fund 28:59 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/175 ADD YOUR VOICE TO THE CONVERSATION I’ve always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.comPhone: (310) 526-2283 And don’t forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn’t allow you to click on these links, you’ll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Give RealTalk MS a Rating and Review National MS Society’s Ask An MS Expert Video Replay What You Need to Know About Coronavirus (COVID-19) National MS Society: Advocate for Change STUDY: Effect of Disease-Modifying Therapy on Disability in Multiple Sclerosis Over 15 Years STUDY: Characterizing Chronic Pain Phenotypes in Multiple Sclerosis: A Nationwide Study RealTalk MS Episode 170: Special MS Pain Episode For More Information About iConquerMS: Website: iConquerMS.org Sara Loud’s Email: sloud@acceleratedcure.org National MS Society COVID-19 Response Fund Join the RealTalk MS Facebook Group Download the RealTalk MS App for iOS Download the RealTalk MS App for Android Give RealTalk MS a Rating and Review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 175 Guests: Sara Loud Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSActivist, iConquerMS, RealTalkMS Privacy Policy

Concepts Keywords
Aging People-powered-research network
Air Web browser
Alexa Care partner protocol
Amazon Healthcare access
Amazon Alexa Tech tools
Amazon Echo Virtual network
Android Online survey
Appropriations Bill Working
Artificial Intelligence Books
Bill Care partner protocol
Biomedical Android
Brain Broadband access
Broadband Drug discovery
Cannabis Drug development
Capitol Hill Virtual community
Care System
Caregiver
Central Nervous System
CEO
Cept
Christmas
Chronic Pain
Clinical Trials
Congress
Coronavirus
Cove
Dashboard
Demographic
Digital
Disability
District
DNA
Drug Development
Echo Dot
Equity
Eso
Europe
Facebook
Focus Group
Force
Frequency
Fumble
Healthcare
Icon
Informed Consent
IOS
Migraine
Momentum
Multiple Sclerosis
Muscle Spasms
Narcotic
Neuropathic Pain
Nikon
Pain
Pandemic
Plastic
Podcast
Progressive
Protocol
Receptors
Register
Short Circuit
Smart Speakers
Society
Stakeholder
Stiffness
Survey
Symptom
Team Michigan
Telehealth
Twitter
Tylenol
United States
Virtual Community
Virtual Network
Washington
Zoo

Semantics

Type Source Name
drug DRUGBANK Tropicamide
disease MESH diagnosis
drug DRUGBANK Coenzyme M
disease MESH Multiple Sclerosis
disease MESH Chronic Pain
drug DRUGBANK Methyltestosterone
disease MESH Privacy
drug DRUGBANK Nonoxynol-9
disease MESH relapses
disease MESH muscle spasms
disease MESH neuropathic pain
disease MESH migraine
drug DRUGBANK Medical Cannabis
disease MESH separated
drug DRUGBANK Medical air
drug DRUGBANK Huperzine B
disease MESH emergency
pathway REACTOME Translation
disease MESH community
drug DRUGBANK Esomeprazole
disease MESH aging
disease MESH development
drug DRUGBANK Spinosad

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *